IQVIA Laboratories bioanalytical solutions for your most complex challenges
As increasing regulatory and scientific complexities threaten R&D productivity, you need a bioanalytical and ADME partner who can truly enhance the drug development process.
IQVIA Laboratories offers complete bioanalytical and ADME laboratory services for testing around the globe and across the product development spectrum. We combine knowledge from the collective services provided by our central labs and bioanalytical and ADME laboratories. The result is timely, high-quality, regulatory compliant data that supplies the insights you need to make more informed decisions and instill confidence in your regulatory filings.
Our bioanalytical laboratory services include:
In vitro ADME assays and metabolite identification services
Including permeability, metabolic stability, metabolite identification (cold & radiolabeled), and in vitro drug-drug interaction risk assessment, ranging from highly automated discovery screening platforms to definitive development studies that enable regulatory submission.
Immunoassay services
Including quantitative determination of large molecule therapeutics using ligand binding assays technologies in support of pharmacokinetic (PK) studies and immunogenicity assays assessments for pre-clinical and clinical studies including tier based approaches, neutralizing assays, and isotyping assays.
Fit-for-purpose biomarker services
Including quantitative determination of large molecule therapeutics using ligand binding assays technologies in support of pharmacokinetic (PK) studies and immunogenicity assays assessments for pre-clinical and clinical studies including tier based approaches, neutralizing assays, and isotyping assays.
Advanced Techniques
We are one of the few bioanalytical laboratories successfully employing immunocapture, multidimensional (up to 3-D) liquid chromatography (LC) and high-resolution mass spectrometry (HRMS) for biological analyte LC/MS quantitation. We have an industry leading reputation in dried-blood spot (DBS) and dried-plasma spot (DPS) microsampling, and are one of the few service labs with experience in utilizing the HμREL® co-culture model to predict clearance and assess metabolic profiles of low turnover compounds.
Customer focus
We excel at employing innovative processes and finding custom solutions for our customers including scheduling flexibility and tailored project management support based on your project’s specific requirements. We know the importance of your deadlines and are willing to commit resources to meet your goals and timelines so you can keep your product on target.
Global Footprint
We serve many of the largest pharmaceutical, specialty pharmaceutical and biotechnology companies in North America, South America, Europe and Asia with scalable expertise and innovative solutions.
Location |
Services |
Indianapolis, IN, USA |
|
Ithaca, NY, USA |
|
RTP, NC, USA |
|
Beijing, China |
|
We not only have the technology, systems, and processes to support your routine and complex projects, but we have 30+ years of experience and industry leading knowledge to provide key insights into the development of your product.
We can also help you develop methods for detecting your small and large molecule therapeutics, and to provide industry leading assays for immunogenicity assessments. The result is reliable, high-quality data for better decision-making, faster, more efficient drug development, and higher quality regulatory submissions.